DNDi and 4 pharmaceutical companies announce 'drug discovery booster' experiment

(Drugs for Neglected Diseases Initiative) DNDi and four pharmaceutical firms, Eisai Co Ltd., Shionogi & Co Ltd., Takeda Pharmaceutical Ltd., and AstraZeneca plc have announced the start of a ground-breaking initiative to accelerate and cut the cost of early stage drug discovery for two of the world's most neglected diseases, leishmaniasis and Chagas disease.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news